Nasus Pharma NSRX
NYSE NSRX
$3.39 +0.33 (+10.79%)
As of: Oct 22, 2026 · 3:21 PM EDT

Nasus Pharma (NSRX) Retained Earnings (2024 - 2026)

Updated

Nasus Pharma (NSRX) posted Retained Earnings of -$24.46 million for Q2 2026, compared with -$13.92 million a year earlier.

Analysis

Nasus Pharma (NSRX) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma's Retained Earnings came in at -$18.52 million.

  • In prior years, Nasus Pharma's Retained Earnings was -$12.66 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,170.23 Bn 1,138.82 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 648.85 Bn 568.71 Bn 17.30 Bn 168.36 Bn
3 AbbVie 504.91 Bn 478.02 Bn 12.70 Bn -17.33 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn -
6 Astrazeneca 268.65 Bn 242.33 Bn 12.86 Bn 12.59 Bn
7 Amgen 242.96 Bn 198.36 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn 2.20 Bn
9 Pfizer 173.22 Bn 119.87 Bn 10.94 Bn 112.09 Bn
10 Nasus Pharma 27.16 Mn 10.45 Mn - -24.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.46 Mn
Dec 31, 2025 -18.52 Mn
Jun 30, 2025 -13.92 Mn
Dec 31, 2024 -12.66 Mn
API Access

Nasus Pharma Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=NSRX&period=max&api_key=YOUR_API_KEY